Physician profile
Bret D Wise
NPI 1457517831
$3,522.57
in general payments reported to CMS, 2019-2025
15 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,563 · 2020: $309 · 2021: $225 · 2022: $489 · 2023: $368 · 2024: $389 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921 · Entertainment: $15.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.05 |
| Entertainment | $15.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,503.57 | 2019-2023 | Myday Contact Lens |
| Alcon Vision LLC | $475.22 | 2019-2025 | Total30, Precision 1 |
| Biotissue Holdings INC. | $337.59 | 2019-2024 | |
| Johnson & Johnson Vision Care, INC. | $256.23 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $219.52 | 2022-2025 | Infuse |
| Genentech USA, INC. | $149.99 | 2023 | Vabysmo |
| Regeneron Healthcare Solutions, INC. | $122.67 | 2025 | Eylea Hd |
| Astellas Pharma US INC | $122.55 | 2024 | Izervay |
| Apellis Pharmaceuticals, INC. | $122.12 | 2024 | Syfovre |
| Ivantis, INC | $67.79 | 2021 | |
| Abbvie INC. | $57.72 | 2022-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $34.79 | 2021 | |
| Allergan, INC. | $25.11 | 2021 | |
| Optos, INC. | $15.56 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Sun Pharmaceutical Industries INC. | $12.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bret Wise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.